BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29068834)

  • 1. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
    Thiébaut R; Hue S; Le Marec F; Lelièvre JD; Dupon M; Foucat E; Lazaro E; Dabis F; Duffau P; Wittkop L; Surenaud M; Pellegrin I; Lacabaratz C; Bonnet F; Lévy Y;
    AIDS; 2017 Nov; 31(17):2355-2365. PubMed ID: 29068834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Soluble Suppression of Tumorigenicity 2 Level Predicts All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients: A Prospective Cohort Study.
    Zhang Z; Shen B; Cao X; Liu Z; Chen X; Nie Y; Yu J; Zou J; Ding X
    Blood Purif; 2017; 43(1-3):37-45. PubMed ID: 27875808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.
    Alladina J; Levy SD; Cho JL; Brait KL; Rao SR; Camacho A; Hibbert KA; Harris RS; Medoff BD; Januzzi JL; Thompson BT; Bajwa EK
    Am J Respir Crit Care Med; 2021 May; 203(10):1257-1265. PubMed ID: 33400890
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
    Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
    Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure.
    Gül İ; Yücel O; Zararsız A; Demirpençe Ö; Yücel H; Zorlu A; Yılmaz MB
    Anatol J Cardiol; 2017 Sep; 18(3):200-205. PubMed ID: 28761021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study.
    Li F; Xu M; Fu M; Cui X; Lian Z; Xin H; Zhou J; Ge J
    BMC Cardiovasc Disord; 2021 Aug; 21(1):396. PubMed ID: 34404341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients.
    Choi YB; Lee MJ; Park JT; Han SH; Kang SW; Yoo TH; Kim HJ
    BMC Nephrol; 2020 Jun; 21(1):228. PubMed ID: 32539731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
    Taylor BS; So-Armah K; Tate JP; Marconi VC; Koethe JR; Bedimo RJ; Butt AA; Gibert CL; Goetz MB; Rodriguez-Barradas MC; Womack JA; Gerschenson M; Lo Re V; Rimland D; Yin MT; Leaf D; Tracy RP; Justice AC; Freiberg MS
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):500-508. PubMed ID: 28696344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation.
    Vílchez JA; Pérez-Cuellar M; Marín F; Gallego P; Manzano-Fernández S; Valdés M; Vicente V; Noguera-Velasco JA; Lip GY; Ordóñez-Llanos J; Roldán V
    Eur J Clin Invest; 2015 Sep; 45(9):899-905. PubMed ID: 26081996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda.
    Siedner MJ; Bwana MB; Asiimwe S; Musinguzi N; Castillo-Mancilla J; Amanyire G; Tracy RP; Bangsberg DR; Orrell C; Haberer JE;
    AIDS; 2019 Nov; 33(13):2043-2048. PubMed ID: 31274541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
    Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
    Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
    Homsak E; Ekart R
    Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
    Chen Y; Qian J
    J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
    Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
    Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.
    Sunil M; Nigalye M; Somasunderam A; Martinez ML; Yu X; Arduino RC; Utay NS; Bell TK
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1205-1209. PubMed ID: 27344921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.